Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 4OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 8Other hematologic neoplasm 7Breast 5Myeloid 4Genitourinary 4Gastrointestinal 4Thoracic 3Head & Neck 3Gynecologic 3Dermatologic 3CNS 2Sarcoma 1Plasma cell 1Other solid neoplasm 1Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Precancerous Conditions 1

Interventions

Sulindac 4Biopsy 4Carboplatin 3Vaginal Smears 2Specimen Handling 2Cyclophosphamide 2Colposcopy 2Aspirin 2tipifarnib 1tanespimycin 1sargramostim 1radium Ra 223 dichloride 1pirfenidone 1fludarabine phosphate 1alethine 1X-Rays 1Taxes 1Sorafenib 1Resistance Training 1Radiotherapy 1Polymerase Chain Reaction 1Photons 1Peripheral Blood Stem Cell Transplantation 1Papanicolaou Test 1Paclitaxel 1Mycophenolic Acid 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Lovastatin 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Polymerase Chain Reaction × Other neoplasm × Clear all
NCT00462813 2013-08-07

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

National Cancer Institute (NCI)

Phase 3 Completed
3,000 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡